Anticonvulsant properties of non-competitive antagonists of the N-methyl-D-aspartate receptor in genetically epilepsy-prone rats : comparison with CPPene

Some non-competitive antagonists of N-methyl-D-aspartate (NMDA) were evaluated for potency to antagonize audiogenic seizures in genetically epilepsy-prone rats, following intraperitoneal administration. Phencyclidine (PCP), dizocilpine (MK-801), ketamine, ifenprodil and dextromethorphan, displayed a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuropharmacology 1993, Vol.32 (1), p.51-58
Hauptverfasser: DE SARRO, G. B, DE SARRO, A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 58
container_issue 1
container_start_page 51
container_title Neuropharmacology
container_volume 32
creator DE SARRO, G. B
DE SARRO, A
description Some non-competitive antagonists of N-methyl-D-aspartate (NMDA) were evaluated for potency to antagonize audiogenic seizures in genetically epilepsy-prone rats, following intraperitoneal administration. Phencyclidine (PCP), dizocilpine (MK-801), ketamine, ifenprodil and dextromethorphan, displayed anticonvulsant activity at doses similar to those which impaired performance in the rotarod equilibrium procedure. The noncompetitive NMDA receptor antagonists, at doses which slightly overlapped with the doses required for a full anticonvulsant protection against audiogenic seizures in genetically epilepsy-prone rats, induced profound untoward behavioural effects. This behavioural syndrome was characterized by marked ataxia, hyperactivity, stereotypes and wet dog shakes. In contrast, the effective anticonvulsant dose of 3-(2-carboxypiperazin-4-yl)propenyl-1-phosphonic acid (CPPene) was less than that required to impair rotarod performance and did not produce the PCP-like syndrome. A potential use in antiepileptic therapy, of CPPene or other new selective NMDA antagonists, with fewer neurotoxic effects but not for non-competitive antagonists such as MK-801, is suggested.
doi_str_mv 10.1016/0028-3908(93)90129-Q
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_16515712</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16515712</sourcerecordid><originalsourceid>FETCH-LOGICAL-c277t-e29ba574d77d14ea5566634691fac116cbe262b7f273beba3a7bec3adc3c913e3</originalsourceid><addsrcrecordid>eNo9kc1uEzEUhS0EKqHwBiB5gRAsDP4be8yuCr9SBa0Ea8vj3GmMZuyp7RTlUXhbnDbKyovznXOtcxB6yeh7Rpn6QCnviTC0f2vEO0MZN-T6EVqxXguiqZKP0eqEPEXPSvlDKZU968_QWU-N5EKu0L-LWINP8W43FRcrXnJaINcABacRxxSJT_MCNdRwB7gR7ibFUOq9XLeAf5AZ6nY_kU_ElcXl6irgDB6WmjIOEd9AbHbvpmmPYQkTLGVP2pnYMNdyPuLDBZdDSRH_DXWL11dXzfMcPRndVODF8T1Hv798_rX-Ri5_fv2-vrgknmtdCXAzuE7LjdYbJsF1nVJKSGXY6Dxjyg_AFR_0yLUYYHDC6QG8cBsvvGECxDl685Db_nS7g1LtHIqHaXIR0q5YpjrWacYbKB9An1MpGUa75DC7vLeM2sMi9lC3PdRtjbD3i9jrZnt1zN8NM2xOpuMETX991F1pLY3ZRR_KCZMdl4pJ8R_Xapfr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16515712</pqid></control><display><type>article</type><title>Anticonvulsant properties of non-competitive antagonists of the N-methyl-D-aspartate receptor in genetically epilepsy-prone rats : comparison with CPPene</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>DE SARRO, G. B ; DE SARRO, A</creator><creatorcontrib>DE SARRO, G. B ; DE SARRO, A</creatorcontrib><description>Some non-competitive antagonists of N-methyl-D-aspartate (NMDA) were evaluated for potency to antagonize audiogenic seizures in genetically epilepsy-prone rats, following intraperitoneal administration. Phencyclidine (PCP), dizocilpine (MK-801), ketamine, ifenprodil and dextromethorphan, displayed anticonvulsant activity at doses similar to those which impaired performance in the rotarod equilibrium procedure. The noncompetitive NMDA receptor antagonists, at doses which slightly overlapped with the doses required for a full anticonvulsant protection against audiogenic seizures in genetically epilepsy-prone rats, induced profound untoward behavioural effects. This behavioural syndrome was characterized by marked ataxia, hyperactivity, stereotypes and wet dog shakes. In contrast, the effective anticonvulsant dose of 3-(2-carboxypiperazin-4-yl)propenyl-1-phosphonic acid (CPPene) was less than that required to impair rotarod performance and did not produce the PCP-like syndrome. A potential use in antiepileptic therapy, of CPPene or other new selective NMDA antagonists, with fewer neurotoxic effects but not for non-competitive antagonists such as MK-801, is suggested.</description><identifier>ISSN: 0028-3908</identifier><identifier>EISSN: 1873-7064</identifier><identifier>DOI: 10.1016/0028-3908(93)90129-Q</identifier><identifier>PMID: 8094234</identifier><identifier>CODEN: NEPHBW</identifier><language>eng</language><publisher>Oxford: Elsevier</publisher><subject>Acoustic Stimulation ; Adrenergic alpha-Antagonists - pharmacology ; Adrenergic alpha-Antagonists - toxicity ; Animals ; Anticonvulsants - pharmacology ; Anticonvulsants - toxicity ; Anticonvulsants. Antiepileptics. Antiparkinson agents ; Biological and medical sciences ; Dextromethorphan - pharmacology ; Dextromethorphan - toxicity ; Dizocilpine Maleate - pharmacology ; Dizocilpine Maleate - toxicity ; Epilepsy - genetics ; Epilepsy - prevention &amp; control ; Injections, Intraperitoneal ; Ketamine - pharmacology ; Ketamine - toxicity ; Male ; Medical sciences ; Movement - drug effects ; Neuropharmacology ; Pharmacology. Drug treatments ; Phencyclidine - pharmacology ; Phencyclidine - toxicity ; Piperazines - pharmacology ; Piperazines - toxicity ; Piperidines - pharmacology ; Piperidines - toxicity ; Postural Balance - drug effects ; Rats ; Rats, Sprague-Dawley ; Receptors, N-Methyl-D-Aspartate - antagonists &amp; inhibitors</subject><ispartof>Neuropharmacology, 1993, Vol.32 (1), p.51-58</ispartof><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c277t-e29ba574d77d14ea5566634691fac116cbe262b7f273beba3a7bec3adc3c913e3</citedby><cites>FETCH-LOGICAL-c277t-e29ba574d77d14ea5566634691fac116cbe262b7f273beba3a7bec3adc3c913e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,4025,27928,27929,27930</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4524614$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8094234$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DE SARRO, G. B</creatorcontrib><creatorcontrib>DE SARRO, A</creatorcontrib><title>Anticonvulsant properties of non-competitive antagonists of the N-methyl-D-aspartate receptor in genetically epilepsy-prone rats : comparison with CPPene</title><title>Neuropharmacology</title><addtitle>Neuropharmacology</addtitle><description>Some non-competitive antagonists of N-methyl-D-aspartate (NMDA) were evaluated for potency to antagonize audiogenic seizures in genetically epilepsy-prone rats, following intraperitoneal administration. Phencyclidine (PCP), dizocilpine (MK-801), ketamine, ifenprodil and dextromethorphan, displayed anticonvulsant activity at doses similar to those which impaired performance in the rotarod equilibrium procedure. The noncompetitive NMDA receptor antagonists, at doses which slightly overlapped with the doses required for a full anticonvulsant protection against audiogenic seizures in genetically epilepsy-prone rats, induced profound untoward behavioural effects. This behavioural syndrome was characterized by marked ataxia, hyperactivity, stereotypes and wet dog shakes. In contrast, the effective anticonvulsant dose of 3-(2-carboxypiperazin-4-yl)propenyl-1-phosphonic acid (CPPene) was less than that required to impair rotarod performance and did not produce the PCP-like syndrome. A potential use in antiepileptic therapy, of CPPene or other new selective NMDA antagonists, with fewer neurotoxic effects but not for non-competitive antagonists such as MK-801, is suggested.</description><subject>Acoustic Stimulation</subject><subject>Adrenergic alpha-Antagonists - pharmacology</subject><subject>Adrenergic alpha-Antagonists - toxicity</subject><subject>Animals</subject><subject>Anticonvulsants - pharmacology</subject><subject>Anticonvulsants - toxicity</subject><subject>Anticonvulsants. Antiepileptics. Antiparkinson agents</subject><subject>Biological and medical sciences</subject><subject>Dextromethorphan - pharmacology</subject><subject>Dextromethorphan - toxicity</subject><subject>Dizocilpine Maleate - pharmacology</subject><subject>Dizocilpine Maleate - toxicity</subject><subject>Epilepsy - genetics</subject><subject>Epilepsy - prevention &amp; control</subject><subject>Injections, Intraperitoneal</subject><subject>Ketamine - pharmacology</subject><subject>Ketamine - toxicity</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Movement - drug effects</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Phencyclidine - pharmacology</subject><subject>Phencyclidine - toxicity</subject><subject>Piperazines - pharmacology</subject><subject>Piperazines - toxicity</subject><subject>Piperidines - pharmacology</subject><subject>Piperidines - toxicity</subject><subject>Postural Balance - drug effects</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, N-Methyl-D-Aspartate - antagonists &amp; inhibitors</subject><issn>0028-3908</issn><issn>1873-7064</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kc1uEzEUhS0EKqHwBiB5gRAsDP4be8yuCr9SBa0Ea8vj3GmMZuyp7RTlUXhbnDbKyovznXOtcxB6yeh7Rpn6QCnviTC0f2vEO0MZN-T6EVqxXguiqZKP0eqEPEXPSvlDKZU968_QWU-N5EKu0L-LWINP8W43FRcrXnJaINcABacRxxSJT_MCNdRwB7gR7ibFUOq9XLeAf5AZ6nY_kU_ElcXl6irgDB6WmjIOEd9AbHbvpmmPYQkTLGVP2pnYMNdyPuLDBZdDSRH_DXWL11dXzfMcPRndVODF8T1Hv798_rX-Ri5_fv2-vrgknmtdCXAzuE7LjdYbJsF1nVJKSGXY6Dxjyg_AFR_0yLUYYHDC6QG8cBsvvGECxDl685Db_nS7g1LtHIqHaXIR0q5YpjrWacYbKB9An1MpGUa75DC7vLeM2sMi9lC3PdRtjbD3i9jrZnt1zN8NM2xOpuMETX991F1pLY3ZRR_KCZMdl4pJ8R_Xapfr</recordid><startdate>1993</startdate><enddate>1993</enddate><creator>DE SARRO, G. B</creator><creator>DE SARRO, A</creator><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>1993</creationdate><title>Anticonvulsant properties of non-competitive antagonists of the N-methyl-D-aspartate receptor in genetically epilepsy-prone rats : comparison with CPPene</title><author>DE SARRO, G. B ; DE SARRO, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c277t-e29ba574d77d14ea5566634691fac116cbe262b7f273beba3a7bec3adc3c913e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Acoustic Stimulation</topic><topic>Adrenergic alpha-Antagonists - pharmacology</topic><topic>Adrenergic alpha-Antagonists - toxicity</topic><topic>Animals</topic><topic>Anticonvulsants - pharmacology</topic><topic>Anticonvulsants - toxicity</topic><topic>Anticonvulsants. Antiepileptics. Antiparkinson agents</topic><topic>Biological and medical sciences</topic><topic>Dextromethorphan - pharmacology</topic><topic>Dextromethorphan - toxicity</topic><topic>Dizocilpine Maleate - pharmacology</topic><topic>Dizocilpine Maleate - toxicity</topic><topic>Epilepsy - genetics</topic><topic>Epilepsy - prevention &amp; control</topic><topic>Injections, Intraperitoneal</topic><topic>Ketamine - pharmacology</topic><topic>Ketamine - toxicity</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Movement - drug effects</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Phencyclidine - pharmacology</topic><topic>Phencyclidine - toxicity</topic><topic>Piperazines - pharmacology</topic><topic>Piperazines - toxicity</topic><topic>Piperidines - pharmacology</topic><topic>Piperidines - toxicity</topic><topic>Postural Balance - drug effects</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, N-Methyl-D-Aspartate - antagonists &amp; inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DE SARRO, G. B</creatorcontrib><creatorcontrib>DE SARRO, A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Neuropharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DE SARRO, G. B</au><au>DE SARRO, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anticonvulsant properties of non-competitive antagonists of the N-methyl-D-aspartate receptor in genetically epilepsy-prone rats : comparison with CPPene</atitle><jtitle>Neuropharmacology</jtitle><addtitle>Neuropharmacology</addtitle><date>1993</date><risdate>1993</risdate><volume>32</volume><issue>1</issue><spage>51</spage><epage>58</epage><pages>51-58</pages><issn>0028-3908</issn><eissn>1873-7064</eissn><coden>NEPHBW</coden><abstract>Some non-competitive antagonists of N-methyl-D-aspartate (NMDA) were evaluated for potency to antagonize audiogenic seizures in genetically epilepsy-prone rats, following intraperitoneal administration. Phencyclidine (PCP), dizocilpine (MK-801), ketamine, ifenprodil and dextromethorphan, displayed anticonvulsant activity at doses similar to those which impaired performance in the rotarod equilibrium procedure. The noncompetitive NMDA receptor antagonists, at doses which slightly overlapped with the doses required for a full anticonvulsant protection against audiogenic seizures in genetically epilepsy-prone rats, induced profound untoward behavioural effects. This behavioural syndrome was characterized by marked ataxia, hyperactivity, stereotypes and wet dog shakes. In contrast, the effective anticonvulsant dose of 3-(2-carboxypiperazin-4-yl)propenyl-1-phosphonic acid (CPPene) was less than that required to impair rotarod performance and did not produce the PCP-like syndrome. A potential use in antiepileptic therapy, of CPPene or other new selective NMDA antagonists, with fewer neurotoxic effects but not for non-competitive antagonists such as MK-801, is suggested.</abstract><cop>Oxford</cop><pub>Elsevier</pub><pmid>8094234</pmid><doi>10.1016/0028-3908(93)90129-Q</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0028-3908
ispartof Neuropharmacology, 1993, Vol.32 (1), p.51-58
issn 0028-3908
1873-7064
language eng
recordid cdi_proquest_miscellaneous_16515712
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Acoustic Stimulation
Adrenergic alpha-Antagonists - pharmacology
Adrenergic alpha-Antagonists - toxicity
Animals
Anticonvulsants - pharmacology
Anticonvulsants - toxicity
Anticonvulsants. Antiepileptics. Antiparkinson agents
Biological and medical sciences
Dextromethorphan - pharmacology
Dextromethorphan - toxicity
Dizocilpine Maleate - pharmacology
Dizocilpine Maleate - toxicity
Epilepsy - genetics
Epilepsy - prevention & control
Injections, Intraperitoneal
Ketamine - pharmacology
Ketamine - toxicity
Male
Medical sciences
Movement - drug effects
Neuropharmacology
Pharmacology. Drug treatments
Phencyclidine - pharmacology
Phencyclidine - toxicity
Piperazines - pharmacology
Piperazines - toxicity
Piperidines - pharmacology
Piperidines - toxicity
Postural Balance - drug effects
Rats
Rats, Sprague-Dawley
Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors
title Anticonvulsant properties of non-competitive antagonists of the N-methyl-D-aspartate receptor in genetically epilepsy-prone rats : comparison with CPPene
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T19%3A17%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anticonvulsant%20properties%20of%20non-competitive%20antagonists%20of%20the%20N-methyl-D-aspartate%20receptor%20in%20genetically%20epilepsy-prone%20rats%20:%20comparison%20with%20CPPene&rft.jtitle=Neuropharmacology&rft.au=DE%20SARRO,%20G.%20B&rft.date=1993&rft.volume=32&rft.issue=1&rft.spage=51&rft.epage=58&rft.pages=51-58&rft.issn=0028-3908&rft.eissn=1873-7064&rft.coden=NEPHBW&rft_id=info:doi/10.1016/0028-3908(93)90129-Q&rft_dat=%3Cproquest_cross%3E16515712%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16515712&rft_id=info:pmid/8094234&rfr_iscdi=true